UNSPSC 51432809: Lisinopril anhydrous

This classification denotes an ace inhibitor with the molecular formula C21H31N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Q3P4BS2FD, chemically known as l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-, but more generally known as lisinopril anhydrous, which bears US NIH Compound Identifier 5362119. European Medicines Agency schedules lisinopril anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08533MIG.

Most nations, for tariff purposes, schedule lisinopril anhydrous under HS 29339990. Lisinopril anhydrous bears US NLM identifiers UMLS ID C2827257 and NCI Concept Code C83924. SMILES: C1CCC(CC1)CC[C@@H](C(=O)O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)O.

UNSPSC 51432809 Lisinopril anhydrous is a Commodity code for a specific antihypertensive pharmaceutical, but state and local recent procurement activity tagged to this code diverges sharply from the nominal scope. The City of Tampa's Fire Rescue division has solicited advanced life support medications under this code classification, but the actual goods being procured—Labetalol HCI, Epinephrine, Adenosine, and Diltiazem vials—do not include lisinopril. The code shows minimal recent activity aligned with its stated product. Issuing bodies at the state and local level that do purchase medications and pharmaceuticals typically include emergency services departments, public health agencies, and hospital systems operated by county or municipal authorities, though the current opportunities block reflects only one active solicitation.

The City of Tampa's Fire Rescue issued an IFB for Advanced Life Support Medications (Solicitation 26P00188, due April 8, 2026) with an estimated contract value of $40,000, requiring delivery within ten calendar days and a nine-month minimum expiration window. The award carries a one-year base term plus two optional one-year renewals and three additional 30-day extensions at the City's discretion. Tampa designated this solicitation with a Small Local Business Enterprise sheltered market set-aside offering a 5 percent bid discount capped at $10,000 for SLBE participation. Vendors must comply with OSHA Hazard Communication Standards, provide Safety Data Sheets, and demonstrate WCAG 2.2 Level AA and Section 508 accessibility conformance. Activity under this code appears limited; the single recent opportunity reflects Florida procurement, though the mismatch between the code's nominal product and the medications actually being solicited suggests this code may not be a reliable indicator of future pharmaceutical procurement patterns in state and local markets.